Nov 22, 2024 / 02:00PM GMT
Unidentified Company Representative
I suggest -- we're still letting people into the room, so just bear with us with a couple more minutes. We would like to ask everyone to be on mute, given the number of people online, so that we do not have interference. And after a very brief presentation of our nine-month results, we'll go into Q&A which we will also ask to be in writing in the box so that we can read it out for everyone.
So we start with our revenues. One can see that we managed to increase our top line in all business segments except for soybean processing. This is a technical -- because of the lower prices for soybean products.
Profitability remains solid on a gross and EBITDA margin. If we are talking about our EBITDA margin, it is stable at 30% courtesy of strong development on the biological assets growing in the ground. And our net profit margin even expanded from 14% to 17%. Without IS41 effect, we also show our profitability on the same page. And it is slightly lower on the gross margin level at 37% and slightly lower on EBITDA margin.
Talking about our cash flows, we
Q3 2024 Astarta Holding PLC Earnings Call Transcript
7 days ago
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers